Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes

12 Apr 2025

Abstract excerpt

BACKGROUND & AIMS: Phosphatidylethanol (PEth) is an ethanol metabolite used as a specific biomarker for recent alcohol consumption. We aimed to determine the proportion of patients with or at risk for metabolic dysfunction-associated steatotic liver disease (MASLD) who had PEth levels indicative of harmful alcohol consumption, and to assess associations between PEth levels and the risk of major adverse liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Consumption and Health Effects
Share to Alcoholism and Thiamine Deficiency
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40228582
DOI: 10.1016/j.jhep.2025.04.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomesPMID 40228582Read ↗

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read ↗

Alcohol-driven phenotypic transition in MASLD and risk of liver-related events.Semantic proximity Read ↗

Impact of phosphatidylethanol in the surveillance for alcohol use in post‐liver transplant population: A retrospective studySemantic proximity Read ↗

Association of the Liver and Plasma Lipidomes with the Histological Stage of Alcohol-Related Liver DiseaseSemantic proximity Read ↗

Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

Molecular Insights into Alcohol-Induced Hepatocarcinogenesis and Comorbidities: Unravelling the Clinical Markers SymphonySemantic proximity Read ↗

Metabolomics-Enhanced Liquid Biopsy Identifies Early Heptocellular Injury in Females with MetALDSemantic proximity Read ↗

The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver diseaseSemantic proximity Read ↗

A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver diseaseSemantic proximity Read ↗

Comprehensive lipidomics reveals reduced hepatic lipid turnover in NAFLD during alcohol intoxicationSemantic proximity Read ↗

Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.Semantic proximity Read ↗

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.